FDA Inspection 655593 — Azurity Pharmaceuticals, Inc.

Azurity Pharmaceuticals, Inc. — FEI 3003395329

The FDA completed an inspection of Azurity Pharmaceuticals, Inc. on March 19, 2010 in Woburn, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 19, 2010
Fiscal Year
2010
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Woburn, MA (United States)

Citations

IDCFRDescription
45421 CFR 820.40(a)Document review, approval by designated individual